Cite

HARVARD Citation

    Leonardi, C. et al. (2019). Comprehensive long‐term safety of adalimumab from 18 clinical trials in adult patients with moderate‐to‐severe plaque psoriasis. British journal of dermatology. pp. 76-85. [Online]. 
  
Back to record